Simeon J. George's most recent trade in Design Therapeutics Inc was a trade of 19,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 46,000 | 46,000 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to buy) | |
| Nkarta Inc | George Simeon J. | Director | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 27 Mar 2024 | 1,548,341 | 1,548,341 | - | 10 | 15,483,410 | Common Stock |
| Nkarta Inc | Simeon George J. | Director | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 27 Mar 2024 | 451,659 | 451,659 | - | 10 | 4,516,590 | Common Stock |
| CRISPR Therapeutics AG | George J. Simeon | Director | Grant, award, or other acquisition of securities at price $ 71.50 per share. | 27 Feb 2024 | 769,196 | 769,196 (1%) | 1% | 71.5 | 54,997,514 | Common Shares |
| CRISPR Therapeutics AG | George Simeon J. | Director | Grant, award, or other acquisition of securities at price $ 71.50 per share. | 27 Feb 2024 | 216,578 | 216,578 (0%) | 0% | 71.5 | 15,485,327 | Common Shares |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 71.50 per share. | 27 Feb 2024 | 63,177 | 63,177 (0%) | 0% | 71.5 | 4,517,156 | Common Shares |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.28 per share. | 16 Dec 2022 | 500,000 | 6,126,476 | - | 8.3 | 4,140,550 | Common Stock |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.63 per share. | 16 Dec 2022 | 360,000 | 6,486,476 | - | 8.6 | 3,108,096 | Common Stock |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.14 per share. | 16 Dec 2022 | 40,000 | 6,526,476 | - | 8.1 | 325,432 | Common Stock |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Simeon J. George | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 28 Apr 2022 | 666,667 | 666,667 | - | 15 | 10,000,005 | Common Stock |
| Nkarta Inc | Simeon J. George | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 28 Apr 2022 | 666,666 | 666,666 | - | 15 | 9,999,990 | Common Stock |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2021 | 16,511 | 16,511 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | 30 Mar 2021 | 7,236,938 | 0 | - | - | Series A Preferred Stock | ||
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | 30 Mar 2021 | 4,439,839 | 4,439,839 | - | - | Common Stock | ||
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | 30 Mar 2021 | 1,526,718 | 0 | - | - | Series B Preferred Stock | ||
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | 30 Mar 2021 | 936,637 | 5,376,476 | - | - | Common Stock | ||
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 30 Mar 2021 | 250,000 | 5,626,476 | - | 20 | 5,000,000 | Common Stock |
| Design Therapeutics Inc | Simeon J. George | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |